Syngene is excited to host ‘Walk the Tox’, a scientific symposium in the area of pre-clinical toxicology. We will hold sessions by industry experts where they share their views on choosing the best strategy for pre-clinical testing and various ways to assess pre-clinical toxicology.
Pre-clinical toxicity assessment is undergoing a dynamic shift from in vivo to in vitro models due to increasingly stringent regulatory requirements. This necessitates a change in the technical capabilities, experimental designs and techniques and re-alignment of company’s pre-clinical risk assessment programs in order to mitigate risks and ensure on time IND filing. This enables timely completion of projects, efficiency, and cost savings.
In this Symposium, we bring you Industry experts Prashant Nambiar, SVP – Research and Development at Strand Therapeutics and Hollie Skaggs, Director – Relay Therapeutics who have many years of experience in the field of gene therapy, immuno-oncology and toxicology to share their experiences and views on the latest trends in the industry.
Time | Session | Speaker |
---|---|---|
1:00pm – 1:15pm | Guest Arrival | |
1:15pm – 2:00pm | Optimal Partnerships in Pre-clinical Drug Development | Kenneth Barr,
Alan Collis |
2:00pm – 2:30pm | Preclinical Considerations for Programmable mRNA Therapies for Enabling Bench to the Clinic Transition | Prashant Nambiar |
2:30pm – 3:00pm | Target Safety Assessment | Hollie Skaggs |
3:00pm – 3:30pm | Accelerating Pre-clinical Tox From Early Discovery to IND Stage | Mohan Krishnappa |
3:30pm – 4:15pm | Refreshments and Networking |
Throughout our 28 years of history, we have worked with well over 1000 companies and are currently the preferred partner to 420+ global organizations. We are also coauthors of 400+ customer patents. Given our history and experience, we have the capability and experience to design a customized journey to take your molecule from early discovery to commercial manufacturing in the shortest possible time. Learn more at www.syngeneintl.com
Syngene International Limited. All rights reserved © 2023
We use cookies to improve your experience on our site and show you information relevant to your requirements.
To find out more, read our Privacy Policy and Cookies Policy.